FDA DEVICE FACTS
Bard Power-Injectable Implantable Ports (PowerPorts®)
C.R. Bard, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The PowerPort® Implantable Port is indicated for patient therapies requiring repeated access to the vascular system. The port system can be used for infusion of medications including anti-cancer medicines (chemotherapy), I.V. fluids, parenteral nutrition solutions, blood products, and for the withdrawal of blood samples.
When used with a PowerLoc® Brand Safety Infusion Set, the PowerPort® device is indicated for power injection of contrast media. For power injection of contrast media, the maximum recommended infusion rate is 5 mL/s.
K063377: The PowerPort® Implanted Port is indicated for patient vascular therapies requiring repeated access to vascular the system. The port system can be used for infusion of medications, I.V. fluids, parenteral nutrition solutions, blood products, and for the withdrawal of blood samples. When used with the PowerLoc Safety Infusion Set, the PowerPort" device is indicated for power injection of contrast media. For power injection of contrast media, the maximum recommended infusion rate is 5 ml/s. K060812, K072215, K072549, K073423, K090512, K081311: The PowerPort® implanted port is indicated for patient therapies requiring repeated access to the vascular system. The port system can be used for infusion of medication, I.V. fluids, parenteral nutrition solutions, blood products, and for the withdrawal of blood samples. When used with a PowerLocTM safety infusion set, the PowerPortTM device is indicated for power injection of contrast media. For power injection of contrast media, the maximum recommended infusion rate is 5 mI/s.
K122899: The PowerPort® ClearVUE® Slim Implantable Port with 8F Polyurethane Catheter is indicated for patient therapies requiring repeated access to the vascular system. The port system can be used for infusion of medications, l.V. fluids, parenteral nutrition solutions, blood products, and for the withdrawal of blood samples. When used with a Powerloc® Safety Infusion Set (SIS), the PowerPort® device is indicated for power injection of contrast media. For power injection of contrast media, the maximum recommended infusion rate is 5 ml/s.
Technological Characteristics No change from predicates Ports are implanted subcutaneously for long-term repeatable vascular access. PowerPorts® are unique in that they can also be power injected with contract media for CT imaging. Features No change from predicates Port Body (including a self-sealing silicone septum), Radiopaque Catheter, CathLock Materials No change from predicates Various Materials Principles of Operation No change from predicates Implantable access device designed to provide repeated access to the vascular system. Sterilization No change from predicates Sterilized to a minimum SAL level of 1 x 10-6 Shelf Life No change from predicates Shelf life for these devices was established by evaluating the physical performance of the ports and catheters with test components either accelerated aged or real time aged to 2 years. Packaging No change from predicates These devices are packaged in three kit configurations: Basic, Intermediate, and Microintroducer. Note: Device Indications for Use in Bold indicates a difference between the subject devices and predicate device. The subject device labeling has been revised/updated to incl ude the expanded Indications for Use language regarding a clarifying statement of “including anti -cancer medicines (chemotherapy)” as related to the infusion of medicines.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。